Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Angiotensinogen promoter and angiotensinogen II receptor type 1 gene polymorphisms and incidence of ischemic stroke and neurologic phenotype in Fabry disease.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals - 1 Nov 2013

Altarescu Gheona, Haim Shimon, Elstein Deborah

Abstract excerpt

CONTEXT: Stroke and/or white matter lesions (WMLs) are significant in Fabry disease. Polymorphisms of angiotensinogen (AGT), AGT Promoter and angiotensinogen II receptor type 1 (AGTR1) are correlated with WMLs. OBJECTIVES: We compared AGT. AGT Promoter and AGTR1 genotypes to stroke incidence, Fabry-specific [Mainz Severity Score Index (MSSI)] severity score, and neurologic sub-score (n-MSSI). METHODS: Sixty-three...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensinogen
Share to Brain Ischemia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fabry Disease

Share to Genetic Association Studies

Share to Incidence

Share to Prevalence

Share to Receptor, Angiotensin, Type 1

Share to Severity of Illness Index

Source

Identifiers

PMID: 24020479
DOI: 10.3109/1354750X.2013.836244

Genes

AGT
AGTR1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Angiotensinogen promoter and angiotensinogen II receptor type 1 gene polymorphisms and incidence of ischemic stroke and neurologic phenotype in Fabry disease.PMID 24020479Read ↗

Effect of genetic modifiers on cerebral lesions in Fabry disease.Semantic proximity Read ↗

Genomic screening of Fabry disease in young stroke patients: the Taiwan experience and a review of the literatureSemantic proximity Read ↗

Genetic aspects of microangiopathy-related cerebral damage.Semantic proximity Read ↗

Prevalence of Fabry Disease in Young Patients with Stroke in Argentina.Semantic proximity Read ↗

[Prevalence of ischemic stroke in young adults and Fabry disease].Semantic proximity Read ↗

JAK2 pathogenic variants in ischemic stroke: low prevalence and pre-screening model.Semantic proximity Read ↗

Nationwide screening for Fabry disease in unselected stroke patients.Semantic proximity Read ↗

Clinical Pregenetic Screening for Stroke Monogenic Diseases: Results From Lombardia GENS Registry.Semantic proximity Read ↗

Cryptogenic stroke and small fiber neuropathy of unknown etiology in patients with alpha-galactosidase A -10T genotype.Semantic proximity Read ↗

Prevalence of Fabry disease and GLA variants in young patients with acute stroke: The challenge to widen the screening. The Fabry-Stroke Italian Registry.Semantic proximity Read ↗

Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study.Semantic proximity Read ↗

Family history of stroke is an independent risk factor for lacunar stroke subtype with asymptomatic lacunar infarcts at younger ages.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.